EP1349548A4 - Methodes et compositions de traitement d'une parodontopathie - Google Patents

Methodes et compositions de traitement d'une parodontopathie

Info

Publication number: EP1349548A4
Authority: EP; European Patent Office
Prior art keywords: periodontopathy; compositions; treating; methods; treating periodontopathy
Prior art date: 2001-01-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP01994350A

Other languages

German (de)

English (en)

Other versions

EP1349548A2 (fr

Inventor

George D Hartman

Sevgi B Rodan

Gideon A Rodan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-03

Filing date

2001-12-28

Publication date

2004-06-02

2001-12-28 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2003-10-08 Publication of EP1349548A2 publication Critical patent/EP1349548A2/fr

2004-06-02 Publication of EP1349548A4 publication Critical patent/EP1349548A4/fr

Status Ceased legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Furan Compounds (AREA)

EP01994350A 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie Ceased EP1349548A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US25944101P	2001-01-03	2001-01-03
US259441P		2001-01-03
PCT/US2001/049638 WO2002053099A2 (fr)	2001-01-03	2001-12-28	Methodes et compositions de traitement d'une parodontopathie

Publications (2)

Publication Number	Publication Date
EP1349548A2 EP1349548A2 (fr)	2003-10-08
EP1349548A4 true EP1349548A4 (fr)	2004-06-02

Family

ID=22984959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01994350A Ceased EP1349548A4 (fr)	2001-01-03	2001-12-28	Methodes et compositions de traitement d'une parodontopathie

Country Status (5)

Country	Link
EP (1)	EP1349548A4 (fr)
JP (1)	JP2004517853A (fr)
AU (1)	AU2002246757B2 (fr)
CA (1)	CA2432504A1 (fr)
WO (1)	WO2002053099A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201305668D0 (en)	2013-03-28	2013-05-15	Glaxosmithkline Ip Dev Ltd	Avs6 Integrin Antagonists
EP3050878B1 (fr)	2013-09-24	2021-10-27	FUJIFILM Corporation	Nouveau composé contenant de l'azote ou son sel, ou son complexe métallique
GB201417002D0 (en)	2014-09-26	2014-11-12	Glaxosmithkline Ip Dev Ltd	Novel compound
GB201417018D0 (en)	2014-09-26	2014-11-12	Glaxosmithkline Ip Dev Ltd	Novel compounds
GB201417011D0 (en)	2014-09-26	2014-11-12	Glaxosmithkline Ip Dev Ltd	Novel compounds
GB201417094D0 (en)	2014-09-26	2014-11-12	Glaxosmithkline Ip Dev Ltd	Novel compounds
GB201604680D0 (en)	2016-03-21	2016-05-04	Glaxosmithkline Ip Dev Ltd	Chemical Compounds

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999031099A1 (fr) *	1997-12-17	1999-06-24	Merck & Co., Inc.	Antagonistes du recepteur de l'integrine
US6017926A (en) *	1997-12-17	2000-01-25	Merck & Co., Inc.	Integrin receptor antagonists
WO2000006169A1 (fr) *	1998-07-29	2000-02-10	Merck & Co., Inc.	Antagonistes des recepteurs de l'integrine
US6048861A (en) *	1997-12-17	2000-04-11	Merck & Co., Inc.	Integrin receptor antagonists
WO2000072801A2 (fr) *	1999-06-02	2000-12-07	Merck & Co., Inc.	Antagonistes du recepteur de l'alpha v integrine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5190981A (en) *	1989-08-17	1993-03-02	Sepracor Inc.	Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US20020028798A1 (en) *	1995-12-12	2002-03-07	Omeros Medical Systems	Irrigation solution and method for inhibition of pain and inflammation
US6136804A (en) *	1998-03-13	2000-10-24	Merck & Co., Inc.	Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions

2001
- 2001-12-28 WO PCT/US2001/049638 patent/WO2002053099A2/fr not_active Ceased
- 2001-12-28 JP JP2002554050A patent/JP2004517853A/ja not_active Withdrawn
- 2001-12-28 CA CA002432504A patent/CA2432504A1/fr not_active Abandoned
- 2001-12-28 EP EP01994350A patent/EP1349548A4/fr not_active Ceased
- 2001-12-28 AU AU2002246757A patent/AU2002246757B2/en not_active Ceased

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999031099A1 (fr) *	1997-12-17	1999-06-24	Merck & Co., Inc.	Antagonistes du recepteur de l'integrine
US6017926A (en) *	1997-12-17	2000-01-25	Merck & Co., Inc.	Integrin receptor antagonists
US6048861A (en) *	1997-12-17	2000-04-11	Merck & Co., Inc.	Integrin receptor antagonists
WO2000006169A1 (fr) *	1998-07-29	2000-02-10	Merck & Co., Inc.	Antagonistes des recepteurs de l'integrine
WO2000072801A2 (fr) *	1999-06-02	2000-12-07	Merck & Co., Inc.	Antagonistes du recepteur de l'alpha v integrine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02053099A3 *

Also Published As

Publication number	Publication date
CA2432504A1 (fr)	2002-07-11
EP1349548A2 (fr)	2003-10-08
WO2002053099A3 (fr)	2002-09-12
WO2002053099A2 (fr)	2002-07-11
JP2004517853A (ja)	2004-06-17
AU2002246757B2 (en)	2006-02-02

Similar Documents

Publication	Publication Date	Title
EP1446114A4 (fr)	2005-05-25	Compositions et methodes de traitement de l'osteoporose
EP1438062A4 (fr)	2005-06-01	Methodes et compositions pour le traitement de lesions cutanees
EP1796666A4 (fr)	2008-03-19	Methodes et compositions de traitement de l'hyperlipidemie
EP1660009A4 (fr)	2010-02-17	Methodes de traitement de l'endometriose
EP1585482A4 (fr)	2009-09-09	Nouvelles compositions et methodes de traitement du psoriasis
EP1578996A4 (fr)	2007-12-19	Compositions et methodes pour diagnostiquer et traiter des tumeurs
EP1265913A4 (fr)	2004-07-14	Caracterisation d'interactions ligands-grp94 et methodes de purification, de criblage et de traitement associees
EP1628530A4 (fr)	2007-08-29	Procedes et compositions pour la prevention et le traitement de la sepsie
EP1298180A4 (fr)	2005-03-09	Composition hydrofuge et oleofuge
EP1663259A4 (fr)	2009-07-29	Compositions et methodes de traitement du cancer
DE60129522D1 (de)	2007-09-06	Gipszusammensetzungen und dazugehörende verfahren
EP1300963A4 (fr)	2009-03-04	Appareil de traitement d'echos
ATE503461T1 (de)	2011-04-15	Pharmazeutische zusammensetzungen zur behandlung von asthma
EP1391476A4 (fr)	2009-08-26	Composition photoreactive
EP1576110A4 (fr)	2007-11-07	Compositions inhibant la migration cellulaire et methodes et compositions pour le traitement du cancer
EP1480658A4 (fr)	2005-03-16	Procedes concernant le traitement d'une affection vasculaire
EP1575571A4 (fr)	2008-06-25	Compositions et methodes de diagnostic et de traitement d'une tumeur
EP1461076A4 (fr)	2005-03-09	Methodes et compositions permettant de traiter des lesions de l'epithelium respiratoire
DE60310912D1 (de)	2007-02-15	Waschmittelzusammensetzungen und komponenten davon
EP1416799A4 (fr)	2004-11-10	Methodes et compositions de traitement des infections fongiques
EP1089731A4 (fr)	2003-06-18	Compositions et methodes de traitement d'une cholesterolemie elevee
FI20011403L (fi)	2002-12-30	Menetelmä ja koostumukset vatsan sairauksien hoitoon
DE69918842D1 (de)	2004-08-26	Desinfektionszusammensetzungen und verfahren
ATE263777T1 (de)	2004-04-15	Zusammensetzungen zur behandlung von entzündungsreaktionen
EP1651271A4 (fr)	2006-11-08	Compositions et methodes de traitement d'une infection a coronavirus et du sras

Legal Events

Date	Code	Title	Description
2003-08-22	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-10-08	17P	Request for examination filed	Effective date: 20030804
2003-10-08	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-10-08	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2004-06-02	A4	Supplementary search report drawn up and despatched	Effective date: 20040421
2004-10-06	17Q	First examination report despatched	Effective date: 20040824
2006-05-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2006-06-07	18R	Application refused	Effective date: 20060101